Mrozek Ewa, Shapiro Charles L
Division of Hematology/Oncology and Comprehensive Breast Health Services, Ohio State University Medical Center, Columbus, OH 43210, USA.
Clin Adv Hematol Oncol. 2005 Mar;3(3):211-22, 238.
The majority of women treated today for breast cancer are long-term survivors. The overall benefits of adjuvant therapy in women with breast cancer favor treatment even in the subset of patients with node-negative invasive breast cancer. The short- and long-term side effects of combined modality treatment have a significant impact on morbidity and quality of life. Continued emphasis on improving survival, decreasing recurrence, and minimizing treatment toxicity are the goals of ongoing breast cancer research.
如今接受乳腺癌治疗的大多数女性都是长期幸存者。辅助治疗对乳腺癌女性的总体益处表明，即使在淋巴结阴性浸润性乳腺癌患者亚组中，治疗也是有益的。综合治疗方式的短期和长期副作用对发病率和生活质量有重大影响。持续强调提高生存率、降低复发率以及将治疗毒性降至最低是当前乳腺癌研究的目标。
